The novel treatment of the medication represents a exciting breakthrough in the management of the condition. Different to existing medications, tirzepatide affects dual pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide066066.activoblog.com/54171358/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment